Cargando…

Silencing of the Mutant Huntingtin Gene through CRISPR-Cas9 Improves the Mitochondrial Biomarkers in an In Vitro Model of Huntington’s Disease

During the 25-year history of the American Society for Neural Therapy and Repair (ASNTR) there have been several breakthroughs in the area of neurotherapeutics, which was the case during the 2014–2105 year when one of us (GLD) had the privilege of serving as its president. During that year, the use...

Descripción completa

Detalles Bibliográficos
Autores principales: Dunbar, Gary L., Koneru, Sindhuja, Kolli, Nivya, Sandstrom, Michael, Maiti, Panchanan, Rossignol, Julien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628560/
https://www.ncbi.nlm.nih.gov/pubmed/30947515
http://dx.doi.org/10.1177/0963689719840662